“[...] this study proposed that the size of the tumor [...] and lipiodol washout rate could predict the outcome of cTACE in patients with metastatic liver tumors ...

A schematic diagram showing the preparation of a pH-responsive Lipiodol Pickering emulsion-based microreactor for transarterial ferro-embolization therapy of HCC. Nowadays, hepatocellular carcinoma ...

Which is more recommendable as the second line chemotherapy to S-1 for advanced gastric cancer; combination of CPT-11 plus CDDP or weekly paclitaxel? No significant financial relationships to disclose ...

Guerbet announced that the FDA has approved Lipiodol (ethiodized oil) Injection for selective hepatic intra-arterial use for imaging tumors in adults with known hepatocellular carcinoma (HCC).

Injection of lipiodol in a kidney. Injection of lipiodol in a kidney.

Guerbet LLC announced that the company will begin manufacturing Lipiodol (ethiodized oil) Injection in the US and will no longer import the product from France. Guerbet LLC announced that the company ...

Hepatocellular carcinoma (HCC) is currently the third leading cause of cancer-related mortality across the globe. Transarterial embolization (TAE) therapy is the standard of care for most patients ...

Guerbet LLC, USA-- Guerbet, a pioneer in the field of contrast agents with more than 80 years of experience, announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug ...

PRINCETON, N.J., March 25, 2019 /PRNewswire/ -- Guerbet LLC USA, the U.S. affiliate of the global specialist in contrast media products and solutions for diagnostic and interventional imaging, today ...